secwatch.observer — SEC 8-K summary
======================================

Issuer:     ENvue Medical, Inc. (FEED)
CIK:        0001326706
Form:       8-K
Filed at:   2023-11-07T23:59:59+00:00
Accession:  0001493152-23-039650
Event type: regulatory
Sentiment:  positive
Materiality: 0.75
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NanoVibronix UroShield products now on NHS Drug Tariff; stocking order received
-------------------------------------------------------------------------------

- UroShield actuators eligible for full NHS reimbursement effective Nov 1, 2023.
- Received stocking order from UK distributor Peak Medical Limited; products shipped.
- Clinicians can prescribe via Drug Tariff or NHS procurement contract; patients no longer pay.
- CEO states increased demand since Nov 1; production ramped to meet expected growth.
- Partner Peak Medical will educate healthcare providers and accept orders.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1326706/000149315223039650/0001493152-23-039650-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1326706/000149315223039650/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-039650

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer